HighTower Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.43M | Buy |
206,114
+34,720
| +20% | +$1.25M | 0.01% | 923 |
|
|
2025
Q1 | $5.34M | Sell |
171,394
-2,017
| -1% | -$62.8K | 0.01% | 1017 |
|
|
2024
Q4 | $4.42M | Sell |
173,411
-9,177
| -5% | -$234K | 0.01% | 1099 |
|
|
2024
Q3 | $5.15M | Sell |
182,588
-13,624
| -7% | -$384K | 0.01% | 1022 |
|
|
2024
Q2 | $5.18M | Sell |
196,212
-28,212
| -13% | -$744K | 0.01% | 992 |
|
|
2024
Q1 | $6.82M | Buy |
224,424
+49,028
| +28% | +$1.49M | 0.01% | 837 |
|
|
2023
Q4 | $4.93M | Sell |
175,396
-55,748
| -24% | -$1.57M | 0.01% | 976 |
|
|
2023
Q3 | $6.27M | Buy |
231,144
+69,527
| +43% | +$1.88M | 0.01% | 829 |
|
|
2023
Q2 | $4.97M | Sell |
161,617
-2,454
| -1% | -$75.5K | 0.01% | 907 |
|
|
2023
Q1 | $5.9M | Buy |
164,071
+5,118
| +3% | +$184K | 0.01% | 784 |
|
|
2022
Q4 | $6.29M | Sell |
158,953
-8,848
| -5% | -$350K | 0.01% | 760 |
|
|
2022
Q3 | $6.74M | Buy |
167,801
+792
| +0.5% | +$31.8K | 0.02% | 689 |
|
|
2022
Q2 | $7.02M | Buy |
167,009
+15,303
| +10% | +$643K | 0.02% | 684 |
|
|
2022
Q1 | $5.92M | Buy |
151,706
+20,430
| +16% | +$797K | 0.01% | 810 |
|
|
2021
Q4 | $5.24M | Buy |
131,276
+10,861
| +9% | +$433K | 0.01% | 877 |
|
|
2021
Q3 | $4.36M | Buy |
120,415
+2,008
| +2% | +$72.6K | 0.01% | 883 |
|
|
2021
Q2 | $4.85M | Buy |
+118,407
| New | +$4.85M | 0.01% | 801 |
|